CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,787,730 | -24.6% | 494,421 | -2.4% | 0.68% | -24.5% |
| Q1 2024 | $35,516,604 | +34932.8% | 506,584 | -58.3% | 0.90% | -73.1% |
| Q4 2023 | $101,381 | +126.6% | 1,214,284 | -20.1% | 3.37% | +75.7% |
| Q3 2023 | $44,745 | -3.1% | 1,518,831 | +7.3% | 1.92% | +34.0% |
| Q2 2023 | $46,191 | -4.0% | 1,416,031 | +3.6% | 1.43% | -49.9% |
| Q1 2023 | $48,106 | +5.0% | 1,367,023 | +36.7% | 2.86% | +11.8% |
| Q4 2022 | $45,820 | -99.9% | 1,000,000 | 0.0% | 2.56% | +23.6% |
| Q3 2022 | $48,450,000 | -3.3% | 1,000,000 | -21.6% | 2.07% | -22.7% |
| Q2 2022 | $50,095,000 | +36.1% | 1,275,000 | +27.5% | 2.68% | +73.7% |
| Q1 2022 | $36,810,000 | -19.2% | 1,000,000 | 0.0% | 1.54% | +24.6% |
| Q4 2021 | $45,580,000 | -1.9% | 1,000,000 | -23.1% | 1.24% | +18.9% |
| Q3 2021 | $46,462,000 | +369.6% | 1,300,000 | +160.0% | 1.04% | +417.4% |
| Q2 2021 | $9,895,000 | -4.8% | 500,000 | 0.0% | 0.20% | -9.9% |
| Q4 2020 | $10,390,000 | – | 500,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |